Benzinga | Aug 12, 2021 08:09AM EDT

Monopar Therapeutics Q2 EPS $(0.17) Down From $(0.14) YoY

Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.17) per share. This is a 21.43 percent decrease over losses of $(0.14) per share from the same period last year.